Chadi Nabhan

Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer

Russell Z. Szmulewitz, Cody J. Peer, Abiola Ibraheem et al. · Journal of Clinical Oncology · 2018 · 177 citations · Full text

Urology, Purpose Abiraterone Acetate, Medicine +12

Impact of oncogene rearrangement patterns on outcomes in patients with double‐hit non‐Hodgkin lymphoma

Daniel J. Landsburg, Adam M. Petrich, Jeremy S. Abramson et al. · Cancer · 2015 · 83 citations · Full text

Real-world Evidence—What Does It Really Mean?

Chadi Nabhan, Andrew J. Klink, Vinay Prasad · JAMA Oncology · 2019 · 57 citations

Website Uses Cookies, Real-world Evidence, Otolaryngology +13

A phase II study evaluating the toxicity and efficacy of single-agent temsirolimus in chemotherapy-naïve castration-resistant prostate cancer

Kimberly Kruczek, Megan Ratterman, Kathy Tolzien et al. · British Journal of Cancer · 2013 · 54 citations · Full text

Erlotinib Has Moderate Single-agent Activity in Chemotherapy-naïve Castration-resistant Prostate Cancer: Final Results of a Phase II Trial

Chadi Nabhan, Timothy M. Lestingi, Ángel Gálvez et al. · Urology · 2009 · 54 citations

Urology, Phase Ii Trial, Medicine +8